Medinotec Inc (MDNC) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MDNC quarterly Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Medinotec Inc adapts its cash strategy across cycles.
Annual Report, GAAP in USD millions
ITEM
(Feb 28 2026)
12 Months
(Feb 28 2025) (Feb 29 2024) (Feb 28 2022)
Operating Activities
Income0.79
Depreciation & amortization0.08
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.40
Increase (Decrease) in Inventories-0.25
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized-0.02
Interest Expense Other-
Allowance For Loan And Lease Loss Recovery Of Bad Debts-
Accounts Receivable Noncurrent Accrued Interest Writeoff-
Increase Decrease In Operating Lease Liability-0.03
Net Cash Flow From Operations-
Income taxes-0.12
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.26
Increase (Decrease) in Accounts Payable, Trade-0.34
Accrued Expense0.00
Increase (Decrease) in Customer Advances and Deposits0.01
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.13
Discontinued operations0.00
Net Cash flow from Operating Activities0.91
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Cash Used In Note Advances-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings-0.98
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-2.84
Raising Fee Capitalized-
Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents2.77
Interest Income Other0.07
Interest Expense-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.98
Effect of exchange rate on cash flow0.06
Discontinued operations0.00
Free Cash Flow0.91
Total Cash Flow-0.01
4 historic quarters locked

Sign in to unlock the full Medinotec Inc cash flow history.

About Medinotec Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001663577-26-000175

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License